Skip to main content
Inflammatory Intestinal Diseases logoLink to Inflammatory Intestinal Diseases
editorial
. 2022 May 24;7(2):71. doi: 10.1159/000525236

Editorial

Toshifumi Hibi a,*, Gerhard Rogler b
PMCID: PMC9294928  PMID: 35979187

We are delighted to announce that, from April 2022, Inflammatory Intestinal Disease (IID) will become the official journal of the Japanese Society of Inflammatory Bowel Diseases (JSIBD). Founded in 2009 as a study group specializing in IBD, JSIB has grown to become a leading medical association with the mission to advance care and improve the quality of life of IBD patients by promoting research and education in all aspects of inflammatory bowel diseases. The Society consists of over 900 Japanese researchers and health care professionals interested in IBD and organizes an annual scientific meeting to foster collaboration, support wider education, and advance IBD research in Japan.

IID was launched in 2016 under the editorial leadership of Gerhard Rogler and Toshifumi Hibi. The journal aimed to promote the collaboration between clinical and basic science in IBD and related intestinal diseases and contribute to the knowledge exchange between researchers from Western and Eastern countries. This aim does reflect in the composition of the international editorial board with experts from South Korea, China, India, Taiwan, Singapore, Indonesia, Europe, North and South America, South Africa, Brazil, and New Zealand. Three members from JSIBD have now joined the editorial board as Associate Editors.

In 2021, IID has been indexed in Scopus, reflecting the high quality of the journal and articles published. We would like to thank all our authors for submitting their work to the journal and all our editors who kindly accepted to review papers. Their efforts have been indispensable to launch the journal and grow it over the past 6 years.

We are confident that our new collaboration with JSIBD will support the journal's mission to become a key resource for the international IBD community and ultimately contribute to improve the care and quality of life of patients with IBD. We sincerely welcome researchers from all over the world to publish their studies in IID and foster collaboration between Eastern and Western research communities.

Toshifumi Hibi, Gerhard Rogler

Editors-in-Chief, Inflammatory Intestinal Diseases

Conflict of Interest Statement

The authors declare no conflicts of interest.

Funding Sources

No specific funding was associated with the preparation of this editorial.

Author Contributions

Both the authors contributed equally to the preparation of this editorial.


Articles from Inflammatory Intestinal Diseases are provided here courtesy of Karger Publishers

RESOURCES